FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileTranslational Development Acquisition Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
TDACU
Translational Development Acquisition Corp. Stock AnalysisComprehensive stock analysis for Translational Development Acquisition Corp. (TDACU) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisTDACU
TDACU
Translational Development Acquisition Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
TDACU
  1. Home
  2. Stocks
  3. Translational Development Acquisition Corp.

Translational Development Acquisition Corp.

🇺🇸TDACU•NASDAQ

Translational Development Acquisition Corp.

🇺🇸TDACU•NASDAQ
Market cap
$234.60M
Sentiment

Your view on TDACU

Mkt Cap
$234.60M
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Translational Development Acquisition Corp.

Industry
Shell Companies
Sector
Financial Services
CEO
Michael Hoffman
Headquarters
77 Water Street, New York City, NY, US
Industry
Shell Companies
Sector
Financial Services
CEO
Michael Hoffman
Headquarters
77 Water Street, New York City, NY, US
Description

Translational Development Acquisition Corp. (TDACU) functions as a blank check entity, currently lacking any operational businesses or ventures of its own.

Its sole purpose is to identify and complete a significant business combination, which could take the form of a merger, acquisition, asset purchase, share exchange, recapitalization, or other similar transaction with an existing company or companies.

TDACU's strategic focus for this combination is specifically directed towards enterprises engaged in the oil, gas, or broader natural resources industries located within Eastern Europe.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Translational Development Acquisition Corp. from FRC's valuation model, read against the market price. TDACU last traded at $11.34; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Translational Development Acquisition Corp.. Starting points for Translational Development Acquisition Corp.: EPS -$0.37, beta 0.27 — an Shell Companies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Translational Development Acquisition Corp.. Translational Development Acquisition Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Translational Development Acquisition Corp.. Trailing twelve-month EPS for Translational Development Acquisition Corp. stands at -$0.37. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Translational Development Acquisition Corp.. Translational Development Acquisition Corp. has reported as a listed company since 2024. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold TDACU15 companies
Compare TDACU with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • BKHABlack Hawk Acquisition CorporationShell Companies$30M
  • RTACRenatus Tactical Acquisition Corp I Class A Ordinary SharesShell Companies$327M
  • WINVWinVest Acquisition Corp.Shell Companies

More Shell Companies companies

  • FTHAForefront Tech Holdings Acquisition Corp.NASDAQ$104M
  • FTHAWForefront Tech Holdings Acquisition CorpNASDAQ$2M
  • FTIIUFutureTech II Acquisition Corp.OTC
  • FTRAFuturecorp Space Acquisition 1NYSE$227M
  • FUTSFuture Science Holdings Inc.OTC$38,446
  • FVAVFortress Value Acquisition Corp. VNASDAQ$291M
  • FVNFuture Vision II Acquisition Corp.NASDAQ$102M
  • FVNNRFuture Vision II Acquisition Corp.NASDAQ$107M
  • FVNNUFuture Vision II Acquisition Corp.NASDAQ$261M
  • FWACRFuturewave Acquisition Corporation RightsNASDAQ$2M
  • FWACUFuturewave Acquisition Corp.NASDAQ$87M
  • FWACWFuturewave Acquisition Corporation WarrantsNASDAQ$385,181
Open Comparable Analysis
Ownership & News

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Translational Development Acquisition Corp. executives and directors. Shares of Translational Development Acquisition Corp. have traded between $10.31 and $17.29 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Translational Development Acquisition Corp.. Coverage tracks Translational Development Acquisition Corp. within Shell Companies (Financial Services). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Translational Development Acquisition Corp.

TDACU Analysis
Fair
Past3
Growth2
Health5
Profit1
Value1

News

Latest Market News